

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 8.26252707 |
| 2 | actin-myosin filament sliding (GO:0033275) | 8.26252707 |
| 3 | plasma membrane repair (GO:0001778) | 7.19436753 |
| 4 | actin-mediated cell contraction (GO:0070252) | 7.00499747 |
| 5 | regulation of skeletal muscle contraction (GO:0014819) | 6.85791072 |
| 6 | skeletal muscle contraction (GO:0003009) | 5.45494237 |
| 7 | actin filament-based movement (GO:0030048) | 5.43465878 |
| 8 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.37602464 |
| 9 | response to muscle activity (GO:0014850) | 5.33240666 |
| 10 | sarcomere organization (GO:0045214) | 5.17406536 |
| 11 | NADH metabolic process (GO:0006734) | 4.76332421 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.49105327 |
| 13 | regulation of sequestering of triglyceride (GO:0010889) | 4.40796343 |
| 14 | myofibril assembly (GO:0030239) | 4.38133829 |
| 15 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.23929397 |
| 16 | cardiac muscle hypertrophy (GO:0003300) | 4.23753889 |
| 17 | actomyosin structure organization (GO:0031032) | 4.19749286 |
| 18 | striated muscle contraction (GO:0006941) | 4.15210983 |
| 19 | skeletal muscle fiber development (GO:0048741) | 4.10324656 |
| 20 | striated muscle hypertrophy (GO:0014897) | 4.07791477 |
| 21 | muscle contraction (GO:0006936) | 3.96051641 |
| 22 | cardiac myofibril assembly (GO:0055003) | 3.94670811 |
| 23 | skeletal muscle adaptation (GO:0043501) | 3.89179876 |
| 24 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.88311188 |
| 25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.83501009 |
| 26 | glucan catabolic process (GO:0009251) | 3.83055183 |
| 27 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.70127116 |
| 28 | muscle hypertrophy (GO:0014896) | 3.67864836 |
| 29 | myotube cell development (GO:0014904) | 3.61398037 |
| 30 | cellular polysaccharide catabolic process (GO:0044247) | 3.57699194 |
| 31 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.55888494 |
| 32 | muscle system process (GO:0003012) | 3.52093709 |
| 33 | regulation of relaxation of muscle (GO:1901077) | 3.49842822 |
| 34 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.48991963 |
| 35 | extracellular fibril organization (GO:0043206) | 3.48581748 |
| 36 | regulation of cell communication by electrical coupling (GO:0010649) | 3.44986568 |
| 37 | cellular response to epinephrine stimulus (GO:0071872) | 3.38651367 |
| 38 | heart contraction (GO:0060047) | 3.36834078 |
| 39 | heart process (GO:0003015) | 3.36834078 |
| 40 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.36103501 |
| 41 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.36103501 |
| 42 | adult heart development (GO:0007512) | 3.34952611 |
| 43 | cardiac muscle contraction (GO:0060048) | 3.33165705 |
| 44 | response to epinephrine (GO:0071871) | 3.30100499 |
| 45 | regulation of the force of heart contraction (GO:0002026) | 3.28553131 |
| 46 | 2-oxoglutarate metabolic process (GO:0006103) | 3.26763108 |
| 47 | muscle fiber development (GO:0048747) | 3.24121630 |
| 48 | polysaccharide catabolic process (GO:0000272) | 3.20146051 |
| 49 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.17509325 |
| 50 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.16234682 |
| 51 | cardiac muscle cell development (GO:0055013) | 3.12640762 |
| 52 | tricarboxylic acid cycle (GO:0006099) | 3.08496091 |
| 53 | carnitine shuttle (GO:0006853) | 3.06883919 |
| 54 | glycogen metabolic process (GO:0005977) | 3.06193107 |
| 55 | extracellular matrix assembly (GO:0085029) | 3.05156759 |
| 56 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.03255355 |
| 57 | cardiac muscle adaptation (GO:0014887) | 3.01929481 |
| 58 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.01929481 |
| 59 | muscle hypertrophy in response to stress (GO:0003299) | 3.01929481 |
| 60 | negative regulation of protein localization to cell surface (GO:2000009) | 3.00525903 |
| 61 | glucan metabolic process (GO:0044042) | 2.99174061 |
| 62 | cellular glucan metabolic process (GO:0006073) | 2.99174061 |
| 63 | cardiac cell development (GO:0055006) | 2.98816052 |
| 64 | chondrocyte proliferation (GO:0035988) | 2.98761573 |
| 65 | regulation of membrane repolarization (GO:0060306) | 2.98258866 |
| 66 | relaxation of muscle (GO:0090075) | 2.98185980 |
| 67 | regulation of tight junction assembly (GO:2000810) | 2.92332727 |
| 68 | skeletal muscle tissue regeneration (GO:0043403) | 2.91908993 |
| 69 | gluconeogenesis (GO:0006094) | 2.91697065 |
| 70 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.90947623 |
| 71 | striated muscle atrophy (GO:0014891) | 2.90674015 |
| 72 | creatine metabolic process (GO:0006600) | 2.89555775 |
| 73 | response to activity (GO:0014823) | 2.88348712 |
| 74 | cytidine metabolic process (GO:0046087) | 2.88066833 |
| 75 | cytidine catabolic process (GO:0006216) | 2.88066833 |
| 76 | cytidine deamination (GO:0009972) | 2.88066833 |
| 77 | cGMP-mediated signaling (GO:0019934) | 2.87582482 |
| 78 | muscle cell cellular homeostasis (GO:0046716) | 2.84080417 |
| 79 | striated muscle cell development (GO:0055002) | 2.83150110 |
| 80 | regulation of striated muscle contraction (GO:0006942) | 2.81890340 |
| 81 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.81269066 |
| 82 | epithelial cell-cell adhesion (GO:0090136) | 2.81181741 |
| 83 | positive regulation of cation channel activity (GO:2001259) | 2.81136392 |
| 84 | triglyceride catabolic process (GO:0019433) | 2.80233188 |
| 85 | striated muscle tissue development (GO:0014706) | 2.80097942 |
| 86 | lipid particle organization (GO:0034389) | 2.79951296 |
| 87 | fibril organization (GO:0097435) | 2.79944016 |
| 88 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.74813593 |
| 89 | myoblast fusion (GO:0007520) | 2.74793182 |
| 90 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.74353663 |
| 91 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.69938300 |
| 92 | * muscle organ development (GO:0007517) | 2.67413577 |
| 93 | negative regulation of heart growth (GO:0061117) | 2.66333841 |
| 94 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.66333841 |
| 95 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.65546587 |
| 96 | * muscle structure development (GO:0061061) | 2.64582592 |
| 97 | actin filament depolymerization (GO:0030042) | 2.62316468 |
| 98 | skeletal muscle tissue development (GO:0007519) | 2.62132966 |
| 99 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.61737653 |
| 100 | neuromuscular junction development (GO:0007528) | 2.61510182 |
| 101 | fatty acid transmembrane transport (GO:1902001) | 2.58484689 |
| 102 | regulation of p38MAPK cascade (GO:1900744) | 2.58465348 |
| 103 | collagen fibril organization (GO:0030199) | 2.57701178 |
| 104 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.57274402 |
| 105 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.57274402 |
| 106 | regulation of muscle system process (GO:0090257) | 2.56925334 |
| 107 | regulation of muscle contraction (GO:0006937) | 2.56082706 |
| 108 | muscle cell fate commitment (GO:0042693) | 2.56080143 |
| 109 | endocardial cushion development (GO:0003197) | 2.55248534 |
| 110 | striated muscle adaptation (GO:0014888) | 2.54887424 |
| 111 | regulation of actin filament-based movement (GO:1903115) | 2.52770529 |
| 112 | muscle tissue morphogenesis (GO:0060415) | 2.51683453 |
| 113 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.50898323 |
| 114 | axon extension involved in axon guidance (GO:0048846) | 2.50642440 |
| 115 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.50642440 |
| 116 | negative regulation of muscle hypertrophy (GO:0014741) | 2.50396119 |
| 117 | desmosome organization (GO:0002934) | 2.49677851 |
| 118 | negative regulation of catenin import into nucleus (GO:0035414) | 2.49488279 |
| 119 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.48327772 |
| 120 | syncytium formation (GO:0006949) | 2.47773435 |
| 121 | wound healing, spreading of epidermal cells (GO:0035313) | 2.47705825 |
| 122 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.45748054 |
| 123 | muscle cell development (GO:0055001) | 2.45323580 |
| 124 | glycogen biosynthetic process (GO:0005978) | 2.45082768 |
| 125 | glucan biosynthetic process (GO:0009250) | 2.45082768 |
| 126 | glycogen catabolic process (GO:0005980) | 2.44899977 |
| 127 | cell-substrate junction assembly (GO:0007044) | 2.44673140 |
| 128 | stress fiber assembly (GO:0043149) | 2.44472865 |
| 129 | regulation of myoblast differentiation (GO:0045661) | 2.43553589 |
| 130 | positive regulation of myotube differentiation (GO:0010831) | 2.43380577 |
| 131 | response to inactivity (GO:0014854) | 2.42542892 |
| 132 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.41745924 |
| 133 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.41441874 |
| 134 | lung vasculature development (GO:0060426) | 2.40663755 |
| 135 | positive regulation of myoblast differentiation (GO:0045663) | 2.38561353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.86443511 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.24534044 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.89205877 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.82654241 |
| 5 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.60387569 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.32429854 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.27360222 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.17931915 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.16425200 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.16198875 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.10436458 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.03829245 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.03829245 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.97382982 |
| 15 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.97375757 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.89285517 |
| 17 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.82651189 |
| 18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.79735588 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79518748 |
| 20 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.78358326 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.75896450 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.72256172 |
| 23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.71346341 |
| 24 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.71091172 |
| 25 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.70834090 |
| 26 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.70638607 |
| 27 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.70347283 |
| 28 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.70347283 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.70096647 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.68082040 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.61365773 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.60512371 |
| 33 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.59147477 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58573986 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.56748604 |
| 36 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.50221681 |
| 37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.49237823 |
| 38 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.47455480 |
| 39 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.46201717 |
| 40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.46140808 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45908716 |
| 42 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45177939 |
| 43 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.44919215 |
| 44 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.44919215 |
| 45 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.43810572 |
| 46 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.41421596 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41213696 |
| 48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.40521705 |
| 49 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38575941 |
| 50 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.38069089 |
| 51 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.37284970 |
| 52 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.31382135 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30581927 |
| 54 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.28901377 |
| 55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.28143281 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27207458 |
| 57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.26848544 |
| 58 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.26474027 |
| 59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24036296 |
| 60 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23151480 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21432958 |
| 62 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.21084227 |
| 63 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.20228244 |
| 64 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.19886485 |
| 65 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.18976704 |
| 66 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18651806 |
| 67 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.17943443 |
| 68 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.17578312 |
| 69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.14266843 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11007554 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10322141 |
| 72 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.10149098 |
| 73 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09329704 |
| 74 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06704229 |
| 75 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06247227 |
| 76 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05161774 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05113377 |
| 78 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.04341747 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04103345 |
| 80 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03455651 |
| 81 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.02659392 |
| 82 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.01947856 |
| 83 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01583204 |
| 84 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.01039025 |
| 85 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00639591 |
| 86 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.00580820 |
| 87 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00504948 |
| 88 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00193409 |
| 89 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.99431051 |
| 90 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99342330 |
| 91 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99288300 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98892859 |
| 93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.97735404 |
| 94 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96330294 |
| 95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95774510 |
| 96 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.95741492 |
| 97 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95722131 |
| 98 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95089508 |
| 99 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95077725 |
| 100 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94683714 |
| 101 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.93792520 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93004458 |
| 103 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.92106836 |
| 104 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91702006 |
| 105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91650250 |
| 106 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.91187660 |
| 107 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90770265 |
| 108 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89799115 |
| 109 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.89549295 |
| 110 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88345053 |
| 111 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87646337 |
| 112 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87639002 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87341840 |
| 114 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86679408 |
| 115 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.86648925 |
| 116 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86441783 |
| 117 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.85798765 |
| 118 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85795875 |
| 119 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85795875 |
| 120 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85716082 |
| 121 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.85194161 |
| 122 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85086130 |
| 123 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.84563373 |
| 124 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83600741 |
| 125 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82524397 |
| 126 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81875769 |
| 127 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.80997540 |
| 128 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78310136 |
| 129 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.78287394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 4.67263626 |
| 2 | MP0000749_muscle_degeneration | 4.63286772 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 3.95185862 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.69257926 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.59092424 |
| 6 | MP0005275_abnormal_skin_tensile | 3.37011425 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.06234974 |
| 8 | MP0003646_muscle_fatigue | 2.98694767 |
| 9 | MP0000747_muscle_weakness | 2.98565260 |
| 10 | MP0004084_abnormal_cardiac_muscle | 2.71243185 |
| 11 | MP0004087_abnormal_muscle_fiber | 2.67413814 |
| 12 | MP0005620_abnormal_muscle_contractility | 2.63477222 |
| 13 | MP0000750_abnormal_muscle_regeneration | 2.60377158 |
| 14 | MP0002106_abnormal_muscle_physiology | 2.57183852 |
| 15 | MP0000759_abnormal_skeletal_muscle | 2.48332727 |
| 16 | MP0000013_abnormal_adipose_tissue | 2.48039116 |
| 17 | MP0001958_emphysema | 2.31259726 |
| 18 | MP0005369_muscle_phenotype | 2.30139827 |
| 19 | MP0005330_cardiomyopathy | 2.27378452 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.16742970 |
| 21 | MP0002269_muscular_atrophy | 2.15017839 |
| 22 | MP0005503_abnormal_tendon_morphology | 2.06937628 |
| 23 | MP0004130_abnormal_muscle_cell | 2.01140538 |
| 24 | MP0004272_abnormal_basement_membrane | 1.98434806 |
| 25 | MP0003279_aneurysm | 1.88316930 |
| 26 | MP0004215_abnormal_myocardial_fiber | 1.87960222 |
| 27 | MP0002108_abnormal_muscle_morphology | 1.87256318 |
| 28 | MP0002972_abnormal_cardiac_muscle | 1.86386694 |
| 29 | MP0000733_abnormal_muscle_development | 1.83429288 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.81308864 |
| 31 | MP0004233_abnormal_muscle_weight | 1.73888286 |
| 32 | MP0005623_abnormal_meninges_morphology | 1.71350565 |
| 33 | MP0004510_myositis | 1.59415827 |
| 34 | MP0005451_abnormal_body_composition | 1.57588186 |
| 35 | MP0006138_congestive_heart_failure | 1.54872124 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.51761558 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.50348497 |
| 38 | MP0001879_abnormal_lymphatic_vessel | 1.49038251 |
| 39 | MP0008775_abnormal_heart_ventricle | 1.43346681 |
| 40 | MP0010368_abnormal_lymphatic_system | 1.42583554 |
| 41 | MP0009384_cardiac_valve_regurgitation | 1.34064978 |
| 42 | MP0010630_abnormal_cardiac_muscle | 1.33075408 |
| 43 | MP0003137_abnormal_impulse_conducting | 1.30498635 |
| 44 | * MP0001544_abnormal_cardiovascular_syste | 1.27202968 |
| 45 | * MP0005385_cardiovascular_system_phenoty | 1.27202968 |
| 46 | MP0008004_abnormal_stomach_pH | 1.26754148 |
| 47 | MP0009250_abnormal_appendicular_skeleto | 1.26042235 |
| 48 | * MP0004484_altered_response_of | 1.24350668 |
| 49 | MP0000003_abnormal_adipose_tissue | 1.21046128 |
| 50 | MP0001661_extended_life_span | 1.20136603 |
| 51 | MP0001299_abnormal_eye_distance/ | 1.17712545 |
| 52 | MP0010030_abnormal_orbit_morphology | 1.13636586 |
| 53 | MP0005375_adipose_tissue_phenotype | 1.11086357 |
| 54 | MP0004270_analgesia | 1.09461022 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 1.08875031 |
| 56 | MP0003385_abnormal_body_wall | 1.08854116 |
| 57 | MP0005666_abnormal_adipose_tissue | 1.08663778 |
| 58 | MP0005266_abnormal_metabolism | 1.08287799 |
| 59 | MP0003045_fibrosis | 1.04226031 |
| 60 | MP0002234_abnormal_pharynx_morphology | 1.00792821 |
| 61 | MP0000534_abnormal_ureter_morphology | 1.00535119 |
| 62 | MP0004085_abnormal_heartbeat | 0.97776217 |
| 63 | MP0004185_abnormal_adipocyte_glucose | 0.95585784 |
| 64 | MP0004858_abnormal_nervous_system | 0.94045456 |
| 65 | MP0002295_abnormal_pulmonary_circulatio | 0.92838747 |
| 66 | MP0000762_abnormal_tongue_morphology | 0.90507069 |
| 67 | MP0005670_abnormal_white_adipose | 0.90263319 |
| 68 | MP0000516_abnormal_urinary_system | 0.89301241 |
| 69 | MP0005367_renal/urinary_system_phenotyp | 0.89301241 |
| 70 | MP0005508_abnormal_skeleton_morphology | 0.87567863 |
| 71 | MP0002127_abnormal_cardiovascular_syste | 0.86641863 |
| 72 | MP0005595_abnormal_vascular_smooth | 0.83459252 |
| 73 | MP0002896_abnormal_bone_mineralization | 0.81680623 |
| 74 | MP0000767_abnormal_smooth_muscle | 0.81637516 |
| 75 | MP0000537_abnormal_urethra_morphology | 0.80455899 |
| 76 | MP0002971_abnormal_brown_adipose | 0.78251700 |
| 77 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77723601 |
| 78 | MP0004134_abnormal_chest_morphology | 0.77649724 |
| 79 | MP0002638_abnormal_pupillary_reflex | 0.76236941 |
| 80 | MP0009115_abnormal_fat_cell | 0.76029040 |
| 81 | MP0003115_abnormal_respiratory_system | 0.74198641 |
| 82 | MP0002876_abnormal_thyroid_physiology | 0.74046446 |
| 83 | MP0010386_abnormal_urinary_bladder | 0.73113448 |
| 84 | MP0000266_abnormal_heart_morphology | 0.72934856 |
| 85 | MP0000230_abnormal_systemic_arterial | 0.72569178 |
| 86 | MP0003091_abnormal_cell_migration | 0.72527608 |
| 87 | MP0005535_abnormal_body_temperature | 0.71903651 |
| 88 | MP0003879_abnormal_hair_cell | 0.71776045 |
| 89 | MP0003959_abnormal_lean_body | 0.71713080 |
| 90 | MP0006276_abnormal_autonomic_nervous | 0.71646678 |
| 91 | MP0002128_abnormal_blood_circulation | 0.70217474 |
| 92 | MP0002133_abnormal_respiratory_system | 0.70166450 |
| 93 | MP0005388_respiratory_system_phenotype | 0.70166450 |
| 94 | MP0002060_abnormal_skin_morphology | 0.70166228 |
| 95 | MP0003828_pulmonary_edema | 0.69880609 |
| 96 | MP0003283_abnormal_digestive_organ | 0.68925130 |
| 97 | MP0000343_altered_response_to | 0.68696226 |
| 98 | MP0002796_impaired_skin_barrier | 0.67384058 |
| 99 | MP0006054_spinal_hemorrhage | 0.67296454 |
| 100 | MP0002249_abnormal_larynx_morphology | 0.67066533 |
| 101 | MP0005334_abnormal_fat_pad | 0.65675393 |
| 102 | MP0002282_abnormal_trachea_morphology | 0.64781373 |
| 103 | MP0008961_abnormal_basal_metabolism | 0.63925887 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.63238503 |
| 105 | MP0003942_abnormal_urinary_system | 0.61780125 |
| 106 | MP0003941_abnormal_skin_development | 0.61340471 |
| 107 | MP0002168_other_aberrant_phenotype | 0.61131217 |
| 108 | MP0001177_atelectasis | 0.59841654 |
| 109 | MP0004859_abnormal_synaptic_plasticity | 0.59179237 |
| 110 | MP0006036_abnormal_mitochondrial_physio | 0.58961564 |
| 111 | MP0002909_abnormal_adrenal_gland | 0.57283718 |
| 112 | MP0005165_increased_susceptibility_to | 0.56564610 |
| 113 | MP0002089_abnormal_postnatal_growth/wei | 0.56560312 |
| 114 | MP0005452_abnormal_adipose_tissue | 0.56131062 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.54850508 |
| 116 | MP0002822_catalepsy | 0.52782883 |
| 117 | MP0003948_abnormal_gas_homeostasis | 0.52296246 |
| 118 | MP0001542_abnormal_bone_strength | 0.50761099 |
| 119 | MP0008569_lethality_at_weaning | 0.46895014 |
| 120 | MP0005187_abnormal_penis_morphology | 0.43466963 |
| 121 | MP0001984_abnormal_olfaction | 0.43417187 |
| 122 | MP0002970_abnormal_white_adipose | 0.43171552 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.41189486 |
| 124 | MP0002114_abnormal_axial_skeleton | 0.38678240 |
| 125 | MP0005448_abnormal_energy_balance | 0.37537112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.54752724 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.21648705 |
| 3 | Nemaline bodies (HP:0003798) | 7.94151235 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 7.74704879 |
| 5 | Distal arthrogryposis (HP:0005684) | 6.23114156 |
| 6 | Exercise-induced myalgia (HP:0003738) | 6.08930316 |
| 7 | Round ear (HP:0100830) | 5.27821080 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 5.25709448 |
| 9 | Muscle fiber splitting (HP:0003555) | 5.12503329 |
| 10 | Myopathic facies (HP:0002058) | 4.97541384 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 4.81754192 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.54511114 |
| 13 | Increased connective tissue (HP:0009025) | 4.54192968 |
| 14 | Calf muscle hypertrophy (HP:0008981) | 4.48032446 |
| 15 | Ulnar deviation of the wrist (HP:0003049) | 4.31040955 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.11792462 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 4.10234401 |
| 18 | Calcaneovalgus deformity (HP:0001848) | 3.96062407 |
| 19 | Difficulty running (HP:0009046) | 3.94754147 |
| 20 | Deformed tarsal bones (HP:0008119) | 3.64799339 |
| 21 | Neck muscle weakness (HP:0000467) | 3.63221808 |
| 22 | Bundle branch block (HP:0011710) | 3.54261321 |
| 23 | Myoglobinuria (HP:0002913) | 3.53948170 |
| 24 | Myotonia (HP:0002486) | 3.52178002 |
| 25 | * Abnormality of skeletal muscle fiber size (HP:0012084) | 3.51417187 |
| 26 | Absent phalangeal crease (HP:0006109) | 3.48529913 |
| 27 | Muscle stiffness (HP:0003552) | 3.25531202 |
| 28 | Sudden death (HP:0001699) | 3.22824712 |
| 29 | * Increased variability in muscle fiber diameter (HP:0003557) | 3.22133778 |
| 30 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.19327729 |
| 31 | Aortic aneurysm (HP:0004942) | 3.07554055 |
| 32 | Difficulty climbing stairs (HP:0003551) | 3.00412493 |
| 33 | Right ventricular cardiomyopathy (HP:0011663) | 2.85163585 |
| 34 | Abnormal finger flexion creases (HP:0006143) | 2.83338021 |
| 35 | * Spinal rigidity (HP:0003306) | 2.81316011 |
| 36 | Facial diplegia (HP:0001349) | 2.76169622 |
| 37 | Slender build (HP:0001533) | 2.74752741 |
| 38 | Abnormality of the calcaneus (HP:0008364) | 2.72544570 |
| 39 | Distal lower limb muscle weakness (HP:0009053) | 2.70661768 |
| 40 | Aortic dissection (HP:0002647) | 2.67008948 |
| 41 | Protrusio acetabuli (HP:0003179) | 2.66679465 |
| 42 | Subaortic stenosis (HP:0001682) | 2.65936601 |
| 43 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.65936601 |
| 44 | * Scapular winging (HP:0003691) | 2.63216656 |
| 45 | Premature rupture of membranes (HP:0001788) | 2.61501739 |
| 46 | Rhabdomyolysis (HP:0003201) | 2.59807923 |
| 47 | Cerebral aneurysm (HP:0004944) | 2.50075254 |
| 48 | Oligomenorrhea (HP:0000876) | 2.43962200 |
| 49 | Hip contracture (HP:0003273) | 2.43174051 |
| 50 | Heart block (HP:0012722) | 2.37450141 |
| 51 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.36964887 |
| 52 | Asymmetric septal hypertrophy (HP:0001670) | 2.36077138 |
| 53 | Generalized muscle weakness (HP:0003324) | 2.33530636 |
| 54 | Ventricular tachycardia (HP:0004756) | 2.33346837 |
| 55 | Broad metatarsal (HP:0001783) | 2.32208027 |
| 56 | Gowers sign (HP:0003391) | 2.30170497 |
| 57 | Abnormal atrioventricular conduction (HP:0005150) | 2.29566660 |
| 58 | Weak cry (HP:0001612) | 2.29291819 |
| 59 | Lipoatrophy (HP:0100578) | 2.26767845 |
| 60 | Muscular dystrophy (HP:0003560) | 2.26731777 |
| 61 | Limb-girdle muscle atrophy (HP:0003797) | 2.26699079 |
| 62 | Areflexia of lower limbs (HP:0002522) | 2.25746529 |
| 63 | Shoulder girdle muscle weakness (HP:0003547) | 2.16064037 |
| 64 | Distal lower limb amyotrophy (HP:0008944) | 2.15271895 |
| 65 | * Frequent falls (HP:0002359) | 2.14291182 |
| 66 | Malignant hyperthermia (HP:0002047) | 2.13235917 |
| 67 | Bulbar palsy (HP:0001283) | 2.12036108 |
| 68 | Proximal amyotrophy (HP:0007126) | 2.07910349 |
| 69 | EMG: neuropathic changes (HP:0003445) | 2.06256583 |
| 70 | * Abnormality of the foot musculature (HP:0001436) | 2.02393042 |
| 71 | Fetal akinesia sequence (HP:0001989) | 2.02296439 |
| 72 | Atrial fibrillation (HP:0005110) | 2.01949865 |
| 73 | * Abnormality of the shoulder girdle musculature (HP:0001435) | 2.01556946 |
| 74 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.01250187 |
| 75 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.01250187 |
| 76 | Limb-girdle muscle weakness (HP:0003325) | 2.00039471 |
| 77 | Tarsal synostosis (HP:0008368) | 1.98573245 |
| 78 | * Rimmed vacuoles (HP:0003805) | 1.98456412 |
| 79 | Pelvic girdle muscle weakness (HP:0003749) | 1.96444768 |
| 80 | Bell-shaped thorax (HP:0001591) | 1.94312911 |
| 81 | Wrist flexion contracture (HP:0001239) | 1.92136039 |
| 82 | Primary atrial arrhythmia (HP:0001692) | 1.90730870 |
| 83 | * Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.87414986 |
| 84 | Hyperkalemia (HP:0002153) | 1.86729193 |
| 85 | Lower limb amyotrophy (HP:0007210) | 1.86284684 |
| 86 | * Foot dorsiflexor weakness (HP:0009027) | 1.85906975 |
| 87 | Fatigable weakness (HP:0003473) | 1.81220867 |
| 88 | Abnormality of the neuromuscular junction (HP:0003398) | 1.81220867 |
| 89 | Prolonged QT interval (HP:0001657) | 1.80734404 |
| 90 | Atrioventricular block (HP:0001678) | 1.80520358 |
| 91 | Limited hip movement (HP:0008800) | 1.80084490 |
| 92 | Supraventricular arrhythmia (HP:0005115) | 1.79239459 |
| 93 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.79033163 |
| 94 | Synostosis involving bones of the feet (HP:0009140) | 1.79033163 |
| 95 | Supraventricular tachycardia (HP:0004755) | 1.78352265 |
| 96 | Vascular tortuosity (HP:0004948) | 1.77238581 |
| 97 | Ulnar deviation of finger (HP:0009465) | 1.77039999 |
| 98 | Shallow orbits (HP:0000586) | 1.76711068 |
| 99 | * Dilated cardiomyopathy (HP:0001644) | 1.75243940 |
| 100 | Ankle contracture (HP:0006466) | 1.74398400 |
| 101 | * Waddling gait (HP:0002515) | 1.73592332 |
| 102 | Ventricular arrhythmia (HP:0004308) | 1.70575773 |
| 103 | Neoplasm of the heart (HP:0100544) | 1.67670441 |
| 104 | Atrophic scars (HP:0001075) | 1.67602955 |
| 105 | Metatarsus adductus (HP:0001840) | 1.67399707 |
| 106 | Dilatation of the ascending aorta (HP:0005111) | 1.66333590 |
| 107 | Ragged-red muscle fibers (HP:0003200) | 1.66269635 |
| 108 | Mesomelia (HP:0003027) | 1.64273011 |
| 109 | Infantile muscular hypotonia (HP:0008947) | 1.61754123 |
| 110 | Progressive muscle weakness (HP:0003323) | 1.60289396 |
| 111 | Achilles tendon contracture (HP:0001771) | 1.59961621 |
| 112 | Long clavicles (HP:0000890) | 1.59721977 |
| 113 | Syncope (HP:0001279) | 1.57881600 |
| 114 | Nonprogressive disorder (HP:0003680) | 1.55958066 |
| 115 | Congenital hip dislocation (HP:0001374) | 1.55497870 |
| 116 | Stridor (HP:0010307) | 1.54138300 |
| 117 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.52607995 |
| 118 | Exercise intolerance (HP:0003546) | 1.49386527 |
| 119 | Increased muscle lipid content (HP:0009058) | 1.46804527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.16196270 |
| 2 | TTN | 5.69609113 |
| 3 | PHKG1 | 3.43367247 |
| 4 | PHKG2 | 3.43367247 |
| 5 | PIK3CG | 3.43285298 |
| 6 | MYLK | 2.91808302 |
| 7 | DMPK | 2.62965987 |
| 8 | TRIB3 | 2.47620833 |
| 9 | LIMK1 | 2.21925981 |
| 10 | LATS2 | 2.05554970 |
| 11 | NME1 | 1.81761950 |
| 12 | PIK3CA | 1.79195622 |
| 13 | PDK3 | 1.74966245 |
| 14 | PDK4 | 1.74966245 |
| 15 | NEK1 | 1.67387078 |
| 16 | TIE1 | 1.50602330 |
| 17 | DDR2 | 1.43572350 |
| 18 | EPHB2 | 1.33175495 |
| 19 | MAPKAPK3 | 1.32210643 |
| 20 | ROCK1 | 1.31101031 |
| 21 | TESK1 | 1.28253202 |
| 22 | ERBB3 | 1.28197390 |
| 23 | PTK2B | 1.27552015 |
| 24 | MAP2K3 | 1.27041143 |
| 25 | LMTK2 | 1.26814875 |
| 26 | PDGFRA | 1.22252635 |
| 27 | PDK2 | 1.21701909 |
| 28 | RIPK1 | 1.21567917 |
| 29 | FER | 1.17450657 |
| 30 | PINK1 | 1.16587941 |
| 31 | ILK | 1.16521841 |
| 32 | MUSK | 1.09673213 |
| 33 | PAK3 | 1.08741923 |
| 34 | MAP3K7 | 1.07079707 |
| 35 | EEF2K | 1.05413108 |
| 36 | PAK2 | 1.00846219 |
| 37 | MAPK12 | 0.98637473 |
| 38 | CAMK1 | 0.95115578 |
| 39 | LATS1 | 0.94417241 |
| 40 | TRPM7 | 0.92773695 |
| 41 | EPHA3 | 0.92093816 |
| 42 | TGFBR2 | 0.90557511 |
| 43 | STK38L | 0.89641197 |
| 44 | MAP3K3 | 0.89420011 |
| 45 | PKN2 | 0.86329623 |
| 46 | ZAK | 0.85529459 |
| 47 | MINK1 | 0.81279319 |
| 48 | MAP2K4 | 0.81011809 |
| 49 | MAPK4 | 0.80927545 |
| 50 | ROCK2 | 0.76217606 |
| 51 | CDC42BPA | 0.74011439 |
| 52 | CCNB1 | 0.73739374 |
| 53 | MAPK7 | 0.73677919 |
| 54 | MAP2K1 | 0.72388199 |
| 55 | MAP3K6 | 0.68949161 |
| 56 | PTK2 | 0.68827171 |
| 57 | DYRK1B | 0.67281659 |
| 58 | CAMK2G | 0.65915304 |
| 59 | ARAF | 0.65690888 |
| 60 | CAMK2B | 0.63648576 |
| 61 | SIK1 | 0.62449848 |
| 62 | PAK6 | 0.62143294 |
| 63 | PRKD1 | 0.60852377 |
| 64 | MARK1 | 0.59596549 |
| 65 | CAMK4 | 0.58890700 |
| 66 | MET | 0.57638694 |
| 67 | LRRK2 | 0.54447357 |
| 68 | TAOK1 | 0.52826993 |
| 69 | ERBB4 | 0.52786406 |
| 70 | STK24 | 0.51182418 |
| 71 | KSR2 | 0.50393916 |
| 72 | MAP3K13 | 0.50354145 |
| 73 | SGK2 | 0.49890752 |
| 74 | SGK3 | 0.48949152 |
| 75 | PRKD3 | 0.48668294 |
| 76 | PTK6 | 0.47898726 |
| 77 | AKT2 | 0.47868173 |
| 78 | BCKDK | 0.47841916 |
| 79 | MOS | 0.47698529 |
| 80 | STK38 | 0.46692679 |
| 81 | MARK2 | 0.45936867 |
| 82 | NTRK1 | 0.45476958 |
| 83 | RET | 0.45397085 |
| 84 | CAMK2D | 0.45270468 |
| 85 | BMX | 0.44344460 |
| 86 | SGK223 | 0.43784223 |
| 87 | SGK494 | 0.43784223 |
| 88 | NEK9 | 0.43651015 |
| 89 | PRKAA1 | 0.43560610 |
| 90 | ICK | 0.41668950 |
| 91 | FGFR1 | 0.41219191 |
| 92 | PRKCH | 0.41002560 |
| 93 | DAPK3 | 0.40114143 |
| 94 | PRKACA | 0.39779260 |
| 95 | PRKG1 | 0.39376955 |
| 96 | RPS6KA2 | 0.38009555 |
| 97 | RPS6KA3 | 0.36149815 |
| 98 | PRKACG | 0.35241580 |
| 99 | DAPK2 | 0.35112701 |
| 100 | PRKAA2 | 0.34894339 |
| 101 | PRKACB | 0.34737900 |
| 102 | EPHB1 | 0.33191691 |
| 103 | CAMK2A | 0.32688288 |
| 104 | MAP3K9 | 0.32335710 |
| 105 | KSR1 | 0.32257499 |
| 106 | GRK5 | 0.32236987 |
| 107 | MAP2K6 | 0.31912426 |
| 108 | PLK2 | 0.30910094 |
| 109 | PDPK1 | 0.30635423 |
| 110 | ABL2 | 0.30558038 |
| 111 | PDGFRB | 0.30542729 |
| 112 | PRKCE | 0.30400861 |
| 113 | CDK5 | 0.28376953 |
| 114 | PAK4 | 0.28189463 |
| 115 | TAOK2 | 0.25951718 |
| 116 | PKN1 | 0.25703399 |
| 117 | MAPK11 | 0.25546572 |
| 118 | MAPK10 | 0.24938554 |
| 119 | PRKG2 | 0.24662824 |
| 120 | MTOR | 0.24659074 |
| 121 | CDK14 | 0.24637308 |
| 122 | MAP3K5 | 0.24526283 |
| 123 | MAPK13 | 0.24052106 |
| 124 | ADRBK1 | 0.23526407 |
| 125 | BCR | 0.22703203 |
| 126 | FGFR2 | 0.22483097 |
| 127 | WNK1 | 0.21860016 |
| 128 | MAP3K1 | 0.21608723 |
| 129 | MAP3K11 | 0.20910778 |
| 130 | GSK3A | 0.20711027 |
| 131 | SGK1 | 0.20138682 |
| 132 | RPS6KC1 | 0.18977396 |
| 133 | RPS6KL1 | 0.18977396 |
| 134 | UHMK1 | 0.18921572 |
| 135 | GRK7 | 0.17540996 |
| 136 | AKT3 | 0.15881987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.79747522 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.59940214 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.38222411 |
| 4 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.32034954 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.86170399 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.13919440 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.07268559 |
| 8 | Focal adhesion_Homo sapiens_hsa04510 | 2.04129328 |
| 9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.84579612 |
| 10 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.82937351 |
| 11 | Tight junction_Homo sapiens_hsa04530 | 1.73194436 |
| 12 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.69661549 |
| 13 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.65350728 |
| 14 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60513415 |
| 15 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.55585522 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51243128 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.42447635 |
| 18 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.36384172 |
| 19 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.26063831 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.25780015 |
| 21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25187417 |
| 22 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.24119017 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23786960 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.22772412 |
| 25 | Adherens junction_Homo sapiens_hsa04520 | 1.21187177 |
| 26 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.17659514 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.16494019 |
| 28 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.15596178 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14194995 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.13812762 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.13471584 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.12014193 |
| 33 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.10973655 |
| 34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.10724871 |
| 35 | Amoebiasis_Homo sapiens_hsa05146 | 1.09141597 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.08267664 |
| 37 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05822533 |
| 38 | Insulin resistance_Homo sapiens_hsa04931 | 1.04611019 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03147745 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03109559 |
| 41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.01928523 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01675881 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00274966 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98330246 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97782487 |
| 46 | Circadian entrainment_Homo sapiens_hsa04713 | 0.97386751 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97062482 |
| 48 | Gap junction_Homo sapiens_hsa04540 | 0.95934277 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93278578 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93244596 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91151385 |
| 52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90861107 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 0.90724116 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.90603475 |
| 55 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.89337499 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 0.88397133 |
| 57 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.87919192 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 0.87363788 |
| 59 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.86184369 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83342555 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82730373 |
| 62 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.81940775 |
| 63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81926895 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81557222 |
| 65 | Melanogenesis_Homo sapiens_hsa04916 | 0.79230140 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78756197 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78152020 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77754834 |
| 69 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76339239 |
| 70 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.75727328 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75030842 |
| 72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.72712287 |
| 73 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.71571127 |
| 74 | GABAergic synapse_Homo sapiens_hsa04727 | 0.71302543 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.69776291 |
| 76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69092053 |
| 77 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.68778042 |
| 78 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68068431 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.68014092 |
| 80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67867270 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67866868 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67772246 |
| 83 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67404238 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65935310 |
| 85 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.65756821 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65551867 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65453731 |
| 88 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64925856 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64769602 |
| 90 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.63605043 |
| 91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62655047 |
| 92 | Long-term depression_Homo sapiens_hsa04730 | 0.62483752 |
| 93 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.61261333 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61114965 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59634110 |
| 96 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.59507360 |
| 97 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59401769 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58444012 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56648914 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56576346 |
| 101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55442224 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54173921 |
| 103 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.53539384 |
| 104 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52963652 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52053753 |
| 106 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.51667472 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50377486 |
| 108 | Long-term potentiation_Homo sapiens_hsa04720 | 0.48635147 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47764432 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47620739 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.47380953 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.45967081 |
| 113 | Melanoma_Homo sapiens_hsa05218 | 0.44473109 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43830996 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43753919 |
| 116 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.43585295 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43369075 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41932130 |
| 119 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.41727365 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41510020 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.39608170 |
| 122 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39561364 |
| 123 | Morphine addiction_Homo sapiens_hsa05032 | 0.39447411 |
| 124 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38406405 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36545660 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.32650342 |
| 127 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.30980416 |
| 128 | Lysine degradation_Homo sapiens_hsa00310 | 0.30438460 |
| 129 | Cocaine addiction_Homo sapiens_hsa05030 | 0.30324251 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29822213 |
| 131 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.27962996 |
| 132 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.26283373 |

